# China NMPA Drug Inspection - Anhui Guanghe Traditional Chinese Medicine Co., Ltd. - Stir-fried cocklebur

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anhui-guanghe-traditional-chinese-medicine-co-ltd/00f7b146-6f5d-480d-a943-fc40ec7357f3/
Source feed: China

> China NMPA drug inspection for Anhui Guanghe Traditional Chinese Medicine Co., Ltd. published May 26, 2020. Drug: Stir-fried cocklebur. On May 26, 2020, the Shaanxi Provincial Drug Administration published results from its fifth 2020 inspection cycle, iden

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shaanxi Province Drug Quality Bulletin
- Company Name: Anhui Guanghe Traditional Chinese Medicine Co., Ltd.
- Publication Date: 2020-05-26
- Drug Name: Stir-fried cocklebur
- Inspection Finding: Non-compliant, [inspection required]
- Action Taken: The relevant municipal (county, district) drug regulatory authorities have taken necessary control measures and are investigating and handling the matter in accordance with relevant laws and regulations.
- Summary: On May 26, 2020, the Shaanxi Provincial Drug Administration published results from its fifth 2020 inspection cycle, identifying eight batches of non-compliant drugs. The manufacturers involved include Anguo Runde Pharmaceutical Co., Ltd., Anhui Yuankang Traditional Chinese Medicine Pieces Co., Ltd., Anhui Guanghe Traditional Chinese Medicine Co., Ltd., Shaanxi Kexing Pharmaceutical Co., Ltd., Shaanxi Kangchao Kangjian Pharmaceutical Co., Ltd., and Baoji Hanfang Traditional Chinese Medicine Pieces Co., Ltd. The inspections revealed several quality violations, specifically regarding physical appearance, identification failures, and general purity inspections. Additional issues involved substandard levels of active ingredients and improper extractive measurements. These findings constitute a failure to meet the standards set by the Chinese Pharmacopoeia 2015 Edition (Parts I, IV, and Supplement 1). In response, the provincial administration has directed municipal and county-level regulatory departments to implement immediate control measures on the affected products. These authorities are currently conducting investigations and pursuing legal actions against the responsible entities to ensure public medication safety and strict adherence to pharmaceutical regulations.

Company: https://www.globalkeysolutions.net/companies/anhui-guanghe-traditional-chinese-medicine-co-ltd/f0558122-5599-494d-a3e7-a7671faaedd4/